Chen J et al. have reported that Gankyrin expedites the proliferation of ovarian cancer cells driven by follicle-stimulating hormone via the PI3K/AKT/HIF-1α/cyclin D1 pathway activation [36]. This evidence concerns the gene AKT1 and ovarian cancer.